Alpha-2B-interferon plus floxuridine in metastatic renal cell carcinoma. A phase I-II study. (Q34729388)
scientific article
Language:
Current Data About Alpha-2B-interferon plus floxuridine in metastatic renal cell carcinoma. A phase I-II study.
(P31) (Q13442814)
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

(P50) (Q56798835)
(P1545) 6
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

(P304) 564-568
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

(P407) (Q1860)

(P433) 2
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

(P478) 72
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

(P577) Thursday, July 1, 1993
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

(P921) (Q5462356)
(P887)

(P1433) (Q326041)
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

(P1476) "Alpha-2B-interferon plus floxuridine in metastatic renal cell carcinoma. A phase I-II study" (language: en)
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

(P2093) A Falcone
(P1545) 1
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

C Cianci
(P1545) 2
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

S Ricci
(P1545) 3
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

I Brunetti
(P1545) 4
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

M Bertuccelli
(P1545) 5
(P248)
(P698) 8319188
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8319188%20AND%20SRC:MED&resulttype=core&format=json
(P813) Tuesday, October 29, 2019

(P2860) (Q42052929)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1097-0142%2819930715%2972%3A2%3C564%3A%3AAID-CNCR2820720238%3E3.0.CO%3B2-P
(P813) Sunday, January 21, 2018

other details